On the Mechanisms of Pharmaceutical Pollution of the Environment Risk Reduction

Vladimir S. Belov (), Natalia V. Ivanova () and Alexander I. Samarkin
Additional contact information
Vladimir S. Belov: Pskov State University
Natalia V. Ivanova: Pskov State University
Alexander I. Samarkin: Pskov State University

A chapter in Industry 4.0, 2022, pp 119-128 from Springer

Abstract: Abstract Purpose The purpose of the study is to determine the main mechanisms and measures to reduce the level of environmental risks due to the widespread massive penetration of medicinal principles into the environment and the manifestation of their negative impact on humans. Design/methodology/approach Application of pharmaceuticals in medicine is aimed at preserving population’s health, which contributes to life expectancy and quality of life. Simultaneously with that we can observe increase in the amount of unutilized medicamental waste produced by healthcare facilities and population (non-needed, expired medications), which contributes to deterioration of ecological situation in the environment due to extreme pharmaceutical pollution. Having studied the world leading countries and the Russian Federation experience in the sphere of environment protection, the authors of this work offer a complex of actions and mechanisms aimed at decreasing medical substances concentration in the environment, which will help to improve its level of ecological safety. Findings It is shown that the main mechanisms for reducing environmental risks from medicinal pollution of the biosphere include: 1. Pharmacovigilance, as a mechanism for assessing environmental risks from pollution with new pharmaceuticals and forms. 2. Centers for environmental monitoring of the quality of natural environments, for the organization of control of possible consequences of drug pollution of the biosphere. Originality/value Implementation of the described mechanisms of decreasing pharmaceutical risks of environment contamination will lead to decrease of composition and concentration of pharmaceutical substances and unreliable bio-logically active substances making their way into human’s body via digestive tracts.

Keywords: Ecological and biological risks; Environment; Pharmaceutical substances; Pharmaceutical pollution; Pharmaceutical waste; Risk-reduction mechanisms; Q510; Q530 (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-79496-5_10

Ordering information: This item can be ordered from
http://www.springer.com/9783030794965

DOI: 10.1007/978-3-030-79496-5_10

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().